PhotoMedex To Present At The CIBC World Markets 16th Annual Healthcare Conference

MONTGOMERYVILLE, Pa., Oct. 31 /PRNewswire-FirstCall/ -- PhotoMedex, Inc. announced today that it is scheduled to make an investor presentation at the CIBC World Markets 16th Annual Healthcare Conference at 9:00 a.m. ET on Monday, November 7, 2005. The conference is being held at the Waldorf-Astoria Hotel in New York City November 7-9, 2005.

A live webcast of the Company's presentation at the Conference will be available via a link provided at An archive of the presentation will begin shortly after the presentation time and will be available for 90 days. Web participants are encouraged to go to the Company's website ( at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.

About PhotoMedex

PhotoMedex provides contract medical procedures to hospitals, surgi-centers and doctors' offices, offering a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics, and other surgical specialties. The company is a leader in the development, manufacturing and marketing of medical laser products and services. In addition, as a result of the merger with ProCyte Corporation, PhotoMedex will now develop and market products based on its patented, clinically proven copper peptide technology for skin health, hair care and wound care. The combined company will sell directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including its long-term worldwide license agreement with Neutrogena(R), a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R), VitalCopper(R), Simple Solutions(R) and AquaSante(R).


Some paragraphs of this press release, particularly those describing PhotoMedex' strategies, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1993, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While PhotoMedex is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including difficulties in marketing its products and services, need for capital, competition from other companies and other factors, any of which could have an adverse effect on the business plans of PhotoMedex, its reputation in the industry or its expected financial return from operations. Factors such as these could have an adverse effect on PhotoMedex' results of operations. In light of significant uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by PhotoMedex and its subsidiaries that they will achieve such forward-looking statements.

Contacts: Allen & Caron PhotoMedex, Inc. Matt Clawson (investors) Dennis McGrath, CFO 949-474-4300 215-619-3287

PhotoMedex, Inc.

CONTACT: Investors, Matt Clawson of Allen & Caron, +1-949-474-4300,, for PhotoMedex, Inc.; or Dennis McGrath, CFO ofPhotoMedex, Inc., +1-215-619-3287,

Back to news